Long COVID Patterns in the RECOVER-Adult Study
November 21, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
No Data Available.
Synonyms :
fluticasone
Class :
Corticosteroid and Topical
Brand Name :
No Data Available.
Synonyms :
fluticasone
Class :
Corticosteroid and Topical
Dosage Forms & Strengths
Cream (as propionate), external:
0.05% (15g, 30g, 60g)
Lotion (as propionate), external:
0.05% (60 ml, 120 ml)
Ointment (as propionate), external:
0.0005% (15g, 30g, 60g)
Corticosteroid-responsive Dermatoses
apply thin film ointment to the affected area twice a day
Apply a thin film of cream or lotion to the affected area 1 to 2 times a day
Dosage Forms & Strengths
Cream (as propionate), external:
0.05% (15g, 30g, 60g)
Lotion (as propionate), external:
0.05% (60 ml, 120 ml)
Ointment (as propionate), external:
0.0005% (15g, 30g, 60g)
Infants > 3 months, Children and Adolescents: apply a thin layer of cream or lotion once or twice a day as needed
Refer to adult dosing
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
measles, mumps, rubella, and varicella vaccine, live (Rx)
it may increase the risk of adverse effects of vaccines
measles mumps and rubella vaccine, live
it may increase the risk of adverse effects of vaccines
it may increase the risk of adverse effects of vaccines
smallpox (vaccinia) vaccine, live
it may increase the risk of adverse effects of vaccines
it may increase the risk of adverse effects of vaccines
measles, mumps, rubella, and varicella vaccine, live (Rx)
it may increase the risk of adverse effects of vaccines
measles mumps and rubella vaccine, live
it may increase the risk of adverse effects of vaccines
it may increase the risk of adverse effects of vaccines
smallpox (vaccinia) vaccine, live
it may increase the risk of adverse effects of vaccines
it may increase the risk of adverse effects of vaccines
may decrease the therapeutic effect when combined with covid-19 vaccine
respiratory syncytial virus vaccine, adjuvanted
may decrease the therapeutic effect when combined with influenza virus vaccines
respiratory syncytial virus (RSV) vaccine
may decrease the therapeutic effect when combined with influenza virus vaccines
may decrease the therapeutic effect when combined with influenza virus vaccines
respiratory syncytial virus vaccine, adjuvanted
may decrease the therapeutic effect when combined with influenza virus vaccines
respiratory syncytial virus (RSV) vaccine
may decrease the therapeutic effect when combined with influenza virus vaccines
poliovirus vaccine, live, trivalent
may decrease the therapeutic effect when combined with influenza virus vaccines
poliovirus vaccine inactivated
may decrease the therapeutic effect when combined with influenza virus vaccines
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may decrease the therapeutic effect of hyaluronidase
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
may diminish the bioavailability of Antacids
may diminish the bioavailability of Antacids
aluminum hydroxide/magnesium carbonate
may decrease the bioavailability of antacids
sipuleucel-T: they may decrease the therapeutic effect of corticosteroids
sipuleucel-T: they may decrease the therapeutic effect of corticosteroids
may decrease the therapeutic effect of each other when combined
may decrease the therapeutic effect of each other when combined
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J4
magnesium salts: they may diminish the bioavailability of corticosteroids J4
magnesium salts: they may diminish the bioavailability of corticosteroids J4
magnesium salts: they may diminish the bioavailability of corticosteroids J4
magnesium salts: they may diminish the bioavailability of corticosteroids J4
may decrease the therapeutic effect of immunosuppressants
may decrease the therapeutic effect of immunosuppressants
may decrease the therapeutic effect of immunosuppressants
may decrease the therapeutic effect of immunosuppressants
may decrease the therapeutic effect of immunosuppressants
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may enhance the serum concentration when combined
may increase the hyponatremic effect when combined
indium In-111 capromab pendetide
may decrease the diagnostic effect when combined
indium In-111 capromab pendetide
may decrease the diagnostic effect when combined
It may decrease the antineoplastic effect when combined with Corticosteroids
It may decrease the antineoplastic effect when combined with Corticosteroids
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may reduce the therapeutic effect of immune checkpoint inhibitors
may reduce the therapeutic effect of immune checkpoint inhibitors
may reduce the therapeutic effect of immune checkpoint inhibitors
may reduce the therapeutic effect of immune checkpoint inhibitors
may reduce the therapeutic effect of immune checkpoint inhibitors
may reduce the therapeutic effect of immune checkpoint inhibitors
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of quinolones
may enhance the adverse effect of quinolones
may enhance the adverse effect of quinolones
may enhance the adverse effect of quinolones
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the serum concentration
may increase the serum concentration
bazedoxifene/conjugated estrogens
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
bazedoxifene/conjugated estrogens
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
They may diminish the absorption when combined with bile acid sequestrants
They may diminish the absorption when combined with bile acid sequestrants
may enhance the concentration of serum when combined with fluticasone
may enhance the concentration of serum when combined with fluticasone
may enhance the concentration of serum when combined with fluticasone
may enhance the concentration of serum when combined with fluticasone
may enhance the concentration of serum when combined with fluticasone
It may enhance the risk of adverse effects when combined with Respiratory tract infections
corticosteroids j3: they may increase the anticoagulant effect of anticoagulants
corticosteroids j3: they may increase the anticoagulant effect of anticoagulants
corticosteroids j3: they may increase the anticoagulant effect of anticoagulants
corticosteroids j3: they may increase the anticoagulant effect of anticoagulants
corticosteroids j3: they may increase the anticoagulant effect of anticoagulants
corticosteroids j4: they may increase the anticoagulant effect of anticoagulants
corticosteroids j4: they may increase the anticoagulant effect of anticoagulants
corticosteroids j4: they may increase the anticoagulant effect of anticoagulants
corticosteroids j4: they may increase the anticoagulant effect of anticoagulants
corticosteroids j4: they may increase the anticoagulant effect of anticoagulants
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may diminish the effect of each other when combined
sodium picosulfate, citric acid, and magnesium oxide
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may diminish the effect of each other when combined
sodium picosulfate, citric acid, and magnesium oxide
may diminish the effect of each other when combined
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
relugolix/estradiol/norethindrone
may have an increased fluid-retaining effect when combined with androgens
relugolix/estradiol/norethindrone
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with agents of urea cycle disorder
relugolix/estradiol/norethindrone
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
spironolactone and hydrochlorothiazide
may increase the hypokalemic effect when combined with diuretics
may increase the hypokalemic effect when combined with diuretics
may increase the hypokalemic effect when combined with diuretics
may increase the hypokalemic effect when combined with diuretics
may increase the hypokalemic effect when combined with diuretics
may have an increasingly adverse effect when combined with NSAIDs
may increase the risk or severity of toxic effects when combined
may reduce the rate of absorption of corticosteroids
may reduce the rate of absorption of corticosteroids
choline magnesium trisalicylate
may enhance the adverse effect of corticosteroids
choline magnesium trisalicylate
may enhance the adverse effect of corticosteroids
may increase the hypokalemic effect of amphotericin
may increase the hypokalemic effect of amphotericin
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
It may enhance the serum concentration when combined with Corticosteroids (ophthalmic)
It may enhance the serum concentration when combined with Corticosteroids (ophthalmic)
It may enhance the serum concentration when combined with Corticosteroids (ophthalmic)
It may enhance the serum concentration when combined with Corticosteroids (ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
estrogens esterified/methyltestosterone
may enhance the serum concentration of estrogen derivatives
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
ciprofloxacin inhaled (Pending FDA approval)
May increase the toxic effect of Quinolones
may increase the toxic effect of Acetylcholinesterase Inhibitors
may increase the toxic effect of Acetylcholinesterase Inhibitors
cyproterone and ethinyl estradiol
may enhance the serum concentration of Estrogen Derivatives
etonogestrel/ethinyl estradiol
may increase the serum concentration of estrogen derivatives
may enhance the serum concentration of each other when combined
it may diminish the excretion rate when combined with corifollitropin alfa resulting in an enhanced serum level
it may diminish the excretion rate when combined with corifollitropin alfa resulting in an enhanced serum level
it may diminish the excretion rate when combined with corifollitropin alfa resulting in an enhanced serum level
it may diminish the excretion rate when combined with corifollitropin alfa resulting in an enhanced serum level
it may diminish the excretion rate when combined with corifollitropin alfa resulting in an enhanced serum level
sodium bicarbonate: they may decrease the therapeutic effect of corticosteroids J3
sodium bicarbonate: they may decrease the therapeutic effect of corticosteroids J4
sodium phenylbutyrate: they may decrease the therapeutic effect of corticosteroids J3
probenecid: they may decrease the therapeutic effect of corticosteroids J3
valproic acid: they may decrease the therapeutic effect of corticosteroids J3
may decrease the anti-neoplastic effect of each other when combined
may decrease the anti-neoplastic effect of each other when combined
abiraterone acetate and niraparib
may decrease the therapeutic effect of immunosuppressive Agents
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
bazedoxifene/conjugated estrogens
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
may decrease the therapeutic effect when combined with covid-19 vaccine
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
bazedoxifene/conjugated estrogens
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
Fluticasone furoate and fluticasone propionate influence the activity of different cell types and inflammatory mediators through an unidentified mechanism.
Fluticasone has been shown in vitro to inhibit nuclear factor kappa b, activate glucocorticoid receptors, and prevent pulmonary eosinophilia in rats.
By maintaining the stability of leukocyte lysosomal membranes and inhibiting the release of leukocytes’ harmful acid hydrolases, corticosteroids reduce inflammation.
Frequency defined:
1% to 10%
Burning sense on skin
Eczema
Erythematous rash
Exacerbation of eczema
Pruritus
Skin irritation
Vomiting
Diarrhea
Numbness of fingers
<1%
Folliculitis
Skin infection
Warts
Edema
Immunosuppression
Applications site edema
Blurred vision
None
Contraindication:
Hypersensitivity
Caution:
Ointment form should not use for atopic dermatitis cases.
Use medication at very high dosage for less than two weeks to minimize systemic and local side effects.
Steroid absorption may increase if medium to extremely high potency is applied to the face, folds, or groin.
Pediatric patients may have greater skin surface-to-body mass ratios that makes them more vulnerable to systemic toxicity from equal doses.
Pregnancy consideration: topical corticosteroids for pregnant females are only used if first-line treatments (emollients) are inadequate.
Lactation: Fluticasone (topical) excretion in breast milk is not known.
Pregnancy category:
It reduces complement components, inhibition of histamine activity and kinin release from substrates and reduction of collagen deposition, fibroblast proliferation, and the ensuing creation of scar tissue.
Fluticasone propionate shows comparable activity while it is not known to have an impact on nuclear factor kappa.
Vasoconstriction in the skin is also linked to the topical formulation of fluticasone.
opical medications are only used topically.
Prior to and following the use of fluticasone topical wash the hands thoroughly.
Gently apply a small layer of medication into the afflicted area of skin.
It is available in form of lotion, cream and ointment.
Patient information leaflet
Generic Name: fluticasone (topical)
Why do we use fluticasone (topical)?
Fluticasone (topical) is indicated in the treatment of atopic dermatitis.
It is also useful in managing corticosteroid-responsive dermatoses.
It is a strong steroid that helps to reduce inflammation in the body.
It is also used to treat eczema-related inflammation and itching.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
